Muhammad Orakzai, MD
Hospitalist · Sheboygan, WINPI 1033402672
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $402 and has fallen 91.6% since, to $34 in 2025. Among hospitalist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $22.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$304
- Johnson & Johnson$297
- Novartis$213
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$87
- Pfizer$86
- Boehringer Ingelheim$83
- plus $365 from 12 others
What the payments were for
- Food & beverage$1,435100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $304 |
| Johnson & Johnson | 10 | $297 |
| Novartis | 13 | $213 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $87 |
| Pfizer | 4 | $86 |
| Boehringer Ingelheim | 3 | $83 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $56 |
| Ceribell, Inc. | 1 | $48 |
| Melinta Therapeutics, LLC | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Scpharmaceuticals Inc. | 2 | $33 |
| AstraZeneca | 2 | $29 |
| W. L. Gore & Associates, Inc. | 1 | $26 |
| Amgen | 2 | $25 |
| Insmed, Inc. | 1 | $22 |
| Advanced Respiratory, Inc | 1 | $15 |
| Vapotherm Inc | 1 | $14 |
| Merck | 1 | $11 |
How this compares
$1,435 in reported general payments places this provider in the 95th percentile of 679 hospitalist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 50 | $238 |
| Doxycycline Hyclate | 37 | $232 |
| Atorvastatin Calcium | 21 | $108 |
| Metoprolol Succinate | 19 | $106 |
| Amlodipine Besylate | 16 | $95 |
| Losartan Potassium | 11 | $68 |
| Lisinopril | 14 | $55 |
| Prednisone | 34 | $53 |
| Furosemide | 17 | $42 |
| Cephalexin | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Sheboygan
- Muhammad Bilal AbidMilwaukee$89K
- Aradhana PathakMilwaukee$45K
- Ankur SegonMilwaukee$35K
- Siddhartha SinghMilwaukee$26K
- Carlos MendezMilwaukee$18K
- Harsimran SekhonMilwaukee$11K
- Ashok Akulala Crosse$10K
- Umair BajwaMilwaukee$8K
- Wamiq BandayMilwaukee$6K
- Eduard VasilevskisMadison$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.